Razor Blade Throat? New COVID Subvariant Surge Prompts Health Concerns Amidst Vaccine Policy Turmoil
Razor Blade Throat? New COVID Subvariant Surge Prompts Health Concerns Amidst Vaccine Policy Turmoil

A new COVID-19 subvariant, NB.1.8.1, nicknamed “Nimbus,” is causing a surge in cases in some parts of California and is raising concerns among health officials. Characterized by an intensely painful “razor blade throat” symptom, similar to a throat covered in shards of glass, Nimbus is rapidly becoming dominant nationally.
Data shows Nimbus comprised an estimated 37% of national coronavirus samples in the two weeks ending June 7th, nearly matching the prevalence of the LP.8.1 subvariant. In California, its dominance is even more pronounced, with projections suggesting it accounts for 55% of circulating viruses, a sharp increase from just 2% in April. This rise is accompanied by elevated coronavirus levels in wastewater and a slight uptick in test positivity rates across various California regions, including Los Angeles and Santa Clara counties.
While emergency room visits remain low, the increase in viral load is prompting vigilance. Dr. Elizabeth Hudson of Kaiser Permanente Southern California notes that wastewater surveillance shows varying levels of viral concentration across the state, ranging from low to high depending on the region.
The rise of Nimbus coincides with significant upheaval in national vaccine policy. The recent weakening of CDC vaccine recommendations, particularly concerning pregnant women and children, has drawn sharp criticism from medical organizations. The American College of Obstetricians and Gynecologists and the American Pharmacists Association, among others, have voiced concerns that these changes are not based on scientific evidence. The mass firing of members of the Advisory Committee on Immunization Practices (ACIP) by the U.S. Department of Health and Human Services further fuels anxieties.
Experts like Dr. Yvonne Maldonado of Stanford University strongly emphasize the importance of COVID-19 vaccination, especially for pregnant women and newborns, citing significantly higher rates of complications and hospitalizations in unvaccinated individuals. The dismissal of the ACIP members is viewed as deeply troubling, potentially jeopardizing future vaccine recommendations and access.
Governors of California, Oregon, and Washington have issued a joint statement condemning these actions, highlighting concerns about the integrity and transparency of future vaccine policies. The situation underscores a critical juncture for public health, balancing the resurgence of a concerning COVID-19 variant with the uncertainty surrounding national vaccination strategies.
Disclaimer: This content is aggregated from public sources online. Please verify information independently. If you believe your rights have been infringed, contact us for removal.